Clinical presentation of Puumala virus infections in southern Austria in the peak year 2012

详细信息    查看全文

• 作者：E. Fabian (1)
  T. Valentin (1)
  M. Hoenigl (1)
  R. Krause (1)
  I. Zollner-Schwetz (1)
  
• 刊名：European Journal of Clinical Microbiology & Infectious Diseases
• 出版年：2014
• 出版时间：April 2014
• 年：2014
• 卷：33
• 期：4
• 页码：587-590
• 全文大小：170 KB
• 参考文献：1. Vapalahti O, Mustonen J, Lundkvist A, Henttonen H, Plyusnin A, Vaheri A (2003) Hantavirus infections in Europe. Lancet Infect Dis 3:653-61 10.1016/S1473-3099(03)00774-6" target="_blank" title="It opens in new window">CrossRef
  2. Aberle SW, Lehner P, Ecker M, Aberle JH, Arneitz K, Khanakah G et al (1999) Nephropathia epidemica and puumala virus in Austria. Eur J Clin Microbiol Infect Dis 18:467-72 10.1007/s100960050325" target="_blank" title="It opens in new window">CrossRef
  3. Jonsson CB, Figueiredo LT, Vapalahti O (2010) A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev 23(2):412-41 10.1128/CMR.00062-09" target="_blank" title="It opens in new window">CrossRef
  4. Settergren B (2000) Clinical aspects of nephropathia epidemica (puumala virus infection) in Europe: a review. Scand J Infect Dis 32(2):125-32 10.1080/003655400750045204" target="_blank" title="It opens in new window">CrossRef
  5. Krautkramer E, Kruger DH, Zeier M (2012) Recent outbreaks of hantavirus disease in Germany and in the united states. Kidney Int 82:1243-245 10.1038/ki.2012.359" target="_blank" title="It opens in new window">CrossRef
  6. Aberle SW (2013) Hantavirus-Infektionen in ?sterreich. Virus Epidemiologische Information 22(4):2013
  7. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373-83 10.1016/0021-9681(87)90171-8" target="_blank" title="It opens in new window">CrossRef
  8. Heyman P, Ceianu CS, Christova I, Tordo N, Beersma M, Joao Alves M et al (2011) A five-year perspective on the situation of haemorrhagic fever with renal syndrome and status of the hantavirus reservoirs in Europe, 2005-010. Euro Surveill 16(3)
  9. Heyman P, Vaheri A et al (2008) Situation of hantavirus infections and haemorrhagic fever with renal syndrome in European countries as of December 2006. Euro Surveill 13(28)
  10. Tersago K, Verhagen R, Servais A, Heyman P, Ducoffre G, Leirs H (2009) Hantavirus disease (nephropathia epidemica) in Belgium: effects of tree seed production and climate. Epidemiol Infect 137:250-56 10.1017/S0950268808000940" target="_blank" title="It opens in new window">CrossRef
  11. Poeppl W, Tobudic S, Winkler HM, Faas A, Mooseder G, Burgmann H (2012) Cross-sectional survey of the seroprevalence of puumala hantavirus in Austria. Vector Borne Zoonotic Dis 12(8):709-11 10.1089/vbz.2011.0841" target="_blank" title="It opens in new window">CrossRef
  12. Pettersson L, Thunberg T, Rockl?v J, Klingstr?m J, Evander M, Ahlm C. (2013) Viral load and humoral immune response in association with disease severity in Puumala hantavirus-infected patients-implications for treatment. Clin Microbiol Infect. doi:10.1111/1469-0691.12259
  13. Sundberg E, Hultdin J, Nilsson S, Ahlm C (2011) Evidence of disseminated intravascular coagulation in a hemorrhagic fever with renal syndrome-scoring models and severe illness. PLoS One 6(6):e21134 10.1371/journal.pone.0021134" target="_blank" title="It opens in new window">CrossRef
  14. Settergren B, Juto P, Trollfors B, Wadell G, Norrby SR (1989) Clinical characteristics of nephropathia epidemica in Sweden: prospective study of 74 cases. Rev Infect Dis 11:921-27 10.1093/clinids/11.6.921" target="_blank" title="It opens in new window">CrossRef
  15. Mustonen J, Brummer-Korvenkontio M, Hedman K, Pasternack A, Pietil? K, Vaheri A (1994) Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis 26:7-3 10.3109/00365549409008583" target="_blank" title="It opens in new window">CrossRef
  
• 作者单位：E. Fabian (1)
  T. Valentin (1)
  M. Hoenigl (1)
  R. Krause (1)
  I. Zollner-Schwetz (1)
  
  1. Section of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036, Graz, Austria
  
• ISSN：1435-4373

文摘

In 2012, an extraordinary rise in Puumala infections causing nephropathia epidemica (NE) was observed in southern Austria. We investigated differences in epidemiology, clinical presentation, laboratory results, treatment parameters, and outcome between patients in 2012 and previous years (2007-011). All patients diagnosed with Puumala virus infections between 2007 and 2012 using a point of care Puumala IgM test at the microbiology laboratory, Department of Internal Medicine, Medical University of Graz, were included. In 2012, 42 and in 2007-011 a total of 40 patients were diagnosed with NE. In 2007-011, patients presented more frequently with arthromyalgias (25?% vs 7?%, p--.027), while lower back pain was reported more often in 2012 (21?% vs 5?%, p--.029). Other symptoms occurred at the same rate. In 2012, patients were diagnosed significantly faster (time from first contact with a physician to diagnosis 1.3?±-.2 vs 2.7?±-.4?days, p--.01). Significantly fewer patients required haemodialysis in 2012 (2.4?% vs 20?%, p--.01). There were no significant differences in laboratory parameters between the two groups. In the peak year 2012, patients were diagnosed faster and fewer patients required haemodialysis possibly because of the earlier diagnosis and earlier onset of therapy.